• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持久共识指南:宫颈癌筛查和管理——范围和流程介绍。

Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process.

机构信息

Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.

Health and Community Services Administration, Pima County, Tucson, AZ.

出版信息

J Low Genit Tract Dis. 2024 Apr 1;28(2):117-123. doi: 10.1097/LGT.0000000000000804. Epub 2024 Mar 2.

DOI:10.1097/LGT.0000000000000804
PMID:38446573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11520335/
Abstract

OBJECTIVES

The Enduring Consensus Cervical Cancer Screening and Management Guidelines (Enduring Guidelines) effort is a standing committee to continuously evaluate new technologies and approaches to cervical cancer screening, management, and surveillance.

METHODS AND RESULTS

The Enduring Guidelines process will selectively incorporate new technologies and approaches with adequate supportive data to more effectively improve cancer prevention for high-risk individuals and decrease unnecessary procedures in low-risk individuals. This manuscript describes the structure, process, and methods of the Enduring Guidelines effort. Using systematic literature reviews and primary data sources, risk of precancer will be estimated and recommendations will be made based on risk estimates in the context of established risk-based clinical action thresholds. The Enduring Guidelines process will consider health equity and health disparities by assuring inclusion of diverse populations in the evidence review and risk assessment and by developing recommendations that provide a choice of well-validated strategies that can be adapted to different settings.

CONCLUSIONS

The Enduring Guidelines process will allow updating existing cervical cancer screening and management guidelines rapidly when new technologies are approved or new scientific evidence becomes available.

摘要

目的

持续共识宫颈癌筛查和管理指南(持续指南)工作是一个常设委员会,旨在不断评估宫颈癌筛查、管理和监测的新技术和方法。

方法和结果

持续指南的工作流程将有选择地纳入具有充分支持数据的新技术和方法,以更有效地为高危人群预防癌症,并减少低危人群的不必要程序。本文描述了持续指南工作的结构、流程和方法。使用系统文献回顾和主要数据源,估计癌前风险,并根据既定基于风险的临床行动阈值背景下的风险估计提出建议。持续指南工作将通过确保在证据审查和风险评估中纳入不同人群,以及制定提供多种经过充分验证的策略选择的建议来考虑公平性和健康差异,这些策略可以适应不同的环境。

结论

当新技术获得批准或新的科学证据可用时,持续指南工作流程将允许快速更新现有的宫颈癌筛查和管理指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2f5/11520335/d83902ecce2b/jlgtd-28-117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2f5/11520335/d588ff62282c/jlgtd-28-117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2f5/11520335/c8d3cbd5a56f/jlgtd-28-117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2f5/11520335/d83902ecce2b/jlgtd-28-117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2f5/11520335/d588ff62282c/jlgtd-28-117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2f5/11520335/c8d3cbd5a56f/jlgtd-28-117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2f5/11520335/d83902ecce2b/jlgtd-28-117-g003.jpg

相似文献

1
Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process.持久共识指南:宫颈癌筛查和管理——范围和流程介绍。
J Low Genit Tract Dis. 2024 Apr 1;28(2):117-123. doi: 10.1097/LGT.0000000000000804. Epub 2024 Mar 2.
2
Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee.用于人乳头瘤病毒检测的自行采集阴道样本:持久共识宫颈癌筛查与管理指南委员会的建议
J Low Genit Tract Dis. 2025 Apr 1;29(2):144-152. doi: 10.1097/LGT.0000000000000885. Epub 2025 Feb 21.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines.将扩展基因分型结果应用于宫颈阴道人乳头瘤病毒检测阳性结果的管理:持久指南。
J Low Genit Tract Dis. 2025 Apr 1;29(2):134-143. doi: 10.1097/LGT.0000000000000865. Epub 2025 Jan 10.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations.筛查宫颈癌的预防和早期检测:为加拿大建议提供信息的系统评价方案。
Syst Rev. 2021 Jan 2;10(1):2. doi: 10.1186/s13643-020-01538-9.
7
Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.向前推进——2019 年 ASCCP 基于风险的异常宫颈癌筛查试验和癌前病变管理共识指南及以后:对实验室的影响和建议。
J Am Soc Cytopathol. 2020 Jul-Aug;9(4):291-303. doi: 10.1016/j.jasc.2020.05.002. Epub 2020 May 23.
8
No. 385-Indications for Pelvic Examination.第385号——盆腔检查的适应症
J Obstet Gynaecol Can. 2019 Aug;41(8):1221-1234. doi: 10.1016/j.jogc.2018.12.007.
9
Risk-Based Cervical Consensus Guidelines: Methods to Determine Management if Less Than 5 Years of Data Are Available.基于风险的宫颈共识指南:在数据不足 5 年的情况下确定管理方法。
J Low Genit Tract Dis. 2022 Jul 1;26(3):195-201. doi: 10.1097/LGT.0000000000000685.
10
2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.2019 ASCCP 基于风险的管理共识指南:风险评估方法、推荐管理及验证。
J Low Genit Tract Dis. 2020 Apr;24(2):90-101. doi: 10.1097/LGT.0000000000000528.

引用本文的文献

1
Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee.用于人乳头瘤病毒检测的自行采集阴道样本:持久共识宫颈癌筛查与管理指南委员会的建议
J Low Genit Tract Dis. 2025 Apr 1;29(2):144-152. doi: 10.1097/LGT.0000000000000885. Epub 2025 Feb 21.
2
Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines.将扩展基因分型结果应用于宫颈阴道人乳头瘤病毒检测阳性结果的管理:持久指南。
J Low Genit Tract Dis. 2025 Apr 1;29(2):134-143. doi: 10.1097/LGT.0000000000000865. Epub 2025 Jan 10.
3

本文引用的文献

1
Implementation in action: Collaborating on the transition to primary HPV screening for cervical cancer in the United States.实际行动中的实施:美国宫颈癌初级人乳头瘤病毒筛查转型中的合作
CA Cancer J Clin. 2023 Sep-Oct;73(5):458-460. doi: 10.3322/caac.21786. Epub 2023 Jun 22.
2
Risk-Based Cervical Consensus Guidelines: Methods to Determine Management if Less Than 5 Years of Data Are Available.基于风险的宫颈共识指南:在数据不足 5 年的情况下确定管理方法。
J Low Genit Tract Dis. 2022 Jul 1;26(3):195-201. doi: 10.1097/LGT.0000000000000685.
3
Computable Guidelines and Clinical Decision Support for Cervical Cancer Screening and Management to Improve Outcomes and Health Equity.
Will methylation assays be part of a full molecular strategy to improve clinical management of cervical neoplasia?
甲基化检测会成为改善宫颈肿瘤临床管理的完整分子策略的一部分吗?
Epigenomics. 2024;16(18):1197-1201. doi: 10.1080/17501911.2024.2402684. Epub 2024 Sep 25.
4
Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico.利用7型人乳头瘤病毒mRNA E6/E7检测对自我采集样本进行宫颈癌筛查:来自墨西哥的多中心见解
Cancers (Basel). 2024 Jul 8;16(13):2485. doi: 10.3390/cancers16132485.
计算指南和临床决策支持在宫颈癌筛查和管理中的应用,以改善结局和健康公平性。
J Womens Health (Larchmt). 2022 Apr;31(4):462-468. doi: 10.1089/jwh.2022.0100.
4
The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics.《改善 HPV 风险知情筛查研究(IRIS):设计与基线特征》。
Cancer Epidemiol Biomarkers Prev. 2022 Feb;31(2):486-492. doi: 10.1158/1055-9965.EPI-21-0865. Epub 2021 Nov 17.
5
Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS).为了开展“改善风险知情的 HPV 筛查研究(IRIS)”,我们构建了一个大型的宫颈标本生物库。
J Clin Virol. 2021 Dec;145:105014. doi: 10.1016/j.jcv.2021.105014. Epub 2021 Nov 3.
6
The IARC Perspective on Cervical Cancer Screening.国际癌症研究机构对宫颈癌筛查的观点。
N Engl J Med. 2021 Nov 11;385(20):1908-1918. doi: 10.1056/NEJMsr2030640.
7
Age-specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi.密西西比州一个全州范围内的、多样化的、前瞻性队列研究,该研究入组了正在接受宫颈癌筛查的个体,对其进行了基线时的人乳头瘤病毒和异常细胞学的年龄特异性流行率研究。
Cancer Med. 2021 Dec;10(23):8641-8650. doi: 10.1002/cam4.4340. Epub 2021 Nov 3.
8
STRIDES - STudying Risk to Improve DisparitiES in Cervical Cancer in Mississippi - Design and baseline results of a Statewide Cohort Study.STRIDES - 研究风险以改善密西西比州宫颈癌的差异 - 一项全州队列研究的设计和基线结果。
Prev Med. 2021 Dec;153:106740. doi: 10.1016/j.ypmed.2021.106740. Epub 2021 Jul 20.
9
Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017.2009 年至 2017 年,未参保和服务不足女性的宫颈癌前病变和癌症风险。
Am J Obstet Gynecol. 2021 Apr;224(4):366.e1-366.e32. doi: 10.1016/j.ajog.2020.10.001. Epub 2020 Oct 6.
10
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.普通风险人群的宫颈癌筛查:美国癌症协会 2020 年指南更新。
CA Cancer J Clin. 2020 Sep;70(5):321-346. doi: 10.3322/caac.21628. Epub 2020 Jul 30.